Oxytetracycline Dihydrate (CAS 6153-64-6)

Oxytetracycline Dihydrate, registered under CAS number 6153-64-6, is a dihydrate form of oxytetracycline, a broad-spectrum antibiotic belonging to the tetracycline class, primarily used in research to study bacterial protein synthesis and gene expression. The core mechanism of action of Oxytetracycline Dihydrate involves the inhibition of protein synthesis by binding to the 30S ribosomal subunit of bacteria. This binding interferes with the attachment of aminoacyl-tRNA to the mRNA-ribosome complex at the acceptor (A) site, effectively blocking the addition of new amino acids to the growing polypeptide chain during translation. This interruption in protein synthesis ultimately inhibits bacterial growth and proliferation. In research settings, Oxytetracycline Dihydrate has been extensively used to explore the dynamics of bacterial response to ribosomal inhibition, particularly in understanding how bacteria adapt and potentially develop resistance to such mechanisms. These studies often focus on the genetic mutations that confer resistance, the environmental conditions that favor such adaptations, and the overall impact on bacterial fitness. The compound′s ability to affect a wide range of bacteria makes it an ideal candidate for studies aimed at deciphering complex bacterial behaviors and interactions under controlled laboratory conditions, contributing significantly to our understanding of microbial ecology and molecular biology.